Against the backdrop of social development and evolving lifestyles, metabolic comorbidities have become one of the core issues affecting public health. Dyslipidemia, hyperglycemia, and hypertension are not only highly prevalent and frequently co-occurring but also major contributors to various serious complications such as cardiovascular diseases and chronic kidney disease.

In light of this, the Chengdu High-Tech Medical Association has decided to hold the 12th session of the symposium, "Dyslipidemia, Hyperglycemia, and Hypertension from a Population-Wide Perspective: Management and Challenges of Comorbidities," online on August 23, 2025.

This conference focuses on a "population-wide perspective," aiming to break through the limitations of traditional single-disease management, promote in-depth integration and innovation across multiple disciplines and fields, and facilitate the optimization and dissemination of comprehensive management strategies spanning prevention, diagnosis, and treatment. By establishing a high-level platform for academic exchange, the event will bring together experts and scholars from clinical practice, scientific research, public health, and other domains to discuss challenges and countermeasures in comorbidity management, share the latest research findings and clinical experiences, and thereby contribute solid expertise to improving China’s chronic disease prevention and control system and enhancing population-wide health management capabilities.